Related Experiment Video
Updated: Jun 8, 2026

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
Published on: August 1, 2025
Endocannabinoid overload
Aron H Lichtman1, Jacqueline L Blankman, Benjamin F Cravatt
1The Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA 23298, USA. alichtma@vcu.edu
Abstract:
The signaling capacity of endogenous cannabinoids ("endocannabinoids") is tightly regulated by degradative enzymes. This Perspective highlights a research article in this issue (p. 996) in which the authors show that genetic disruption of monoacylglycerol lipase (MAGL), the principal degradative enzyme for the endocannabinoid 2-arachidonoylglycerol (2-AG), causes marked elevations in 2-AG levels that lead to desensitization of brain cannabinoid receptors. These findings highlight the central role that MAGL plays in endocannabinoid metabolism in vivo and reveal that excessive 2-AG signaling can lead to functional antagonism of the brain cannabinoid system.
Related Concept Videos
Desensitization and Tachyphylaxis
Several...
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Cushing Syndrome II: Pathophysiology
GPCR Desensitization
Analgesia and Pain Management

